Literature DB >> 19131983

JAMA study casts cloud over biologic safety.

Jim Kling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19131983     DOI： 10.1038/nbt0109-11

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

2.  Safety-related regulatory actions for biologicals approved in the United States and the European Union.

Authors:  Thijs J Giezen; Aukje K Mantel-Teeuwisse; Sabine M J M Straus; Huub Schellekens; Hubert G M Leufkens; Antoine C G Egberts
Journal:  JAMA       Date:  2008-10-22       Impact factor: 56.272

3.  Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

Authors:  Frank A Scappaticci; Jamey R Skillings; Scott N Holden; Hans-Peter Gerber; Kathy Miller; Fairooz Kabbinavar; Emily Bergsland; James Ngai; Eric Holmgren; Jiuzhou Wang; Herbert Hurwitz
Journal:  J Natl Cancer Inst       Date:  2007-08-08       Impact factor: 13.506
  3 in total
  1 in total

1.  Complementary MS methods assist conformational characterization of antibodies with altered S-S bonding networks.

Authors:  Lisa M Jones; Hao Zhang; Weidong Cui; Sandeep Kumar; Justin B Sperry; James A Carroll; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2013-03-13       Impact factor: 3.109
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.